Mounjaro Injection: A Dual-Action Solution for Weight and Diabetes Management Mounjaro injection, containing tirzepatide, is a once-weekly injectable medication approved for managing type 2 diabetes and aiding in weight loss. It works by activating two key hormone receptors—GLP-1 and GIP—to regulate blood sugar levels, suppress appetite, and enhance fat metabolism. Administered via a pre-filled pen, Mounjaro is convenient and easy to use. Clinical studies have shown significant results, including improved glucose control and substantial weight reduction. It is prescribed as part of a broader treatment plan, including diet and exercise, and should be used under the supervision of a healthcare provider.